Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

OBJECTIVE: To test the safety, tolerability, and pharmacokinetics of the anti- TNF-α monoclonal antibody, infliximab, in subjects with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD). STUDY DESIGN: We conducted a multicenter, randomized, prospective trial of second IVIG infusion (2...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Burns, Jane C., Best, Brookie M., Mejias, Asuncion, Mahony, Lynn, Fixler, David E., Jafri, Hasan S., Melish, Marian E., Jackson, Mary Anne, Asmar, Basim I., Lang, David J., Connor, James D., Capparelli, Edmund V., Keen, Monica L., Mamun, Khalid, Keenan, Gregory F., Ramilo, Octavio
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856847/
https://ncbi.nlm.nih.gov/pubmed/18672254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2008.06.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi